23 "Batra Sandeep, Md" clinical studies found.

• Phase III Randomized Trial of Post-Radiation Chemotherapy in Patients with Newly Diagnosed Ependymoma Ages 1 to 21 years

  This randomized phase III trial is studying maintenance chemotherapy to see how well it works compared to observation following induction ...

  Batra Sandeep, Md

• A Randomized Phase II Trial of Brentuximab Vedotin (SGN35 NSC# 749710) or Crizotinib (NSC#749005 Commercially Labeled) in Combination With ...

  This partially randomized phase II trial studies how well brentuximab vedotin or crizotinib and combination chemotherapy works in treating patients ...

  Batra Sandeep, Md

• Risk-Stratified Randomized Phase III Testing of Blinatumomab (NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)

  This randomized phase III trial compares how well blinatumomab works compared with standard combination chemotherapy in treating patients with B-cell ...

  Batra Sandeep, Md

• A Phase III Randomized Trial for Newly Diagnosed High Risk B-Lymphoblastic Leukemia (B-ALL) Including a Stratum Evaluating Dasatinib (NSC#732517 ...

  This randomized phase III trial is studying how well combination chemotherapy works in treating young patients with newly diagnosed acute ...

  Batra Sandeep, Md

• The Project: Every Child Protocol: A Registry Eligibility Screening Biology and Outcome Study

  This research trial studies the Project: Every Child for younger patients with cancer. Gathering health information over time from younger ...

  Batra Sandeep, Md

• AGCT1531: A Phase 3 Study of Active Surveillance for Low Risk and a Randomized Trial of Carboplatin vs. Cisplatin for ...

  The purpose of this study is to compare the effects good and/or bad of carboplatin with cisplatin on people ...

  Batra Sandeep, Md

• Phase 2 Trial of XL184 (Cabozantinib) an Oral Small-Molecule Inhibitor of Multiple Kinases in Children and Young Adults With Refractory ...

  This phase II trial studies how well cabozantinib-s-malate works in treating younger patients with sarcomas, Wilms tumor, or other rare ...

  Batra Sandeep, Md

• A Phase 2 Study of Inotuzumab Ozogamicin (NSC# 772518) in Children and Young Adults With Relapsed or Refractory CD22+ B-Acute ...

  This phase II trial studies how well inotuzumab ozogamicin works in treating younger patients with CD22 positive B acute lymphoblastic ...

  Batra Sandeep, Md

• International Phase 3 Trial in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (Ph+ALL) Testing Imatinib in Combination With Two Different Cytotoxic ...

  This randomized phase III trial studies how well imatinib mesylate and combination chemotherapy work in treating patients with newly diagnosed ...

  Batra Sandeep, Md

• NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Screening Protocol

  This screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in pediatric ...

  Batra Sandeep, Md